Investment Director, Innovestor Life Science
InnovestorCheck size: €250K-€3M initial investments depending on strategy. No person-specific check range is inferred for Sara Kangaspeska.
Sara Kangaspeska works on Innovestor's strategy to back Nordic and Baltic early-stage technology and life-science companies with capital, active ownership and commercial support from initial idea through Series A. The firm does not publish a narrower personal mandate on the cited roster.
At firm level, Innovestor seeks founders and companies aligned with its published thesis: Back Nordic and Baltic early-stage technology and life-science companies with capital, active ownership and commercial support from initial idea through Series A.
No person-specific pass list is public. Opportunities outside Innovestor's stated sectors, stages or geography appear less aligned.
Show fit with Innovestor's published sectors and stages, the founder insight, evidence of technical or commercial progress, market scale, capital need and the specific help requested from the team.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Sara Kangaspeska is listed by Innovestor's current official roster as Investment Director, Innovestor Life Science. Where the cited official pages do not provide a personal biography, prior employers, education and deal attribution are intentionally not inferred.